Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY25.52 CNY
Change Today 0.00 / 0.00%
Volume 0.0
600521 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang huahai pharmaceut-a (600521) Snapshot

Open
CNY23.20
Previous Close
CNY25.52
Day High
CNY25.52
Day Low
CNY23.20
52 Week High
05/21/15 - CNY25.52
52 Week Low
06/19/14 - CNY9.81
Market Cap
20.1B
Average Volume 10 Days
10.4M
EPS TTM
CNY0.41
Shares Outstanding
785.9M
EX-Date
05/22/15
P/E TM
62.7x
Dividend
CNY0.15
Dividend Yield
0.59%
Current Stock Chart for ZHEJIANG HUAHAI PHARMACEUT-A (600521)

Related News

No related news articles were found.

zhejiang huahai pharmaceut-a (600521) Related Businessweek News

No Related Businessweek News Found

zhejiang huahai pharmaceut-a (600521) Details

Zhejiang Huahai Pharmaceutical Co., Ltd. manufactures and sells formulations, active pharmaceutical ingredients, and intermediates in China and internationally. It also provides pril products, such as captopril, enalapril, and lisinopril. The company was founded in 1989 and is based in Linhai, China.

Founded in 1989

zhejiang huahai pharmaceut-a (600521) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang huahai pharmaceut-a (600521) Key Developments

Zhejiang Huahai Pharmaceutical Co Ltd. Approves Tax Included Cash Dividend for the Year 2014; Approves Amendments to Articles of Association

Zhejiang Huahai Pharmaceutical Co Ltd. announced that at the AGM held on April 27, 2015, the shareholders have approved tax included cash dividend of CNY 1.5 per ten (tax included) shares for the year 2014. The company also approved the amendments to the company's articles of association.

Zhejiang Huahai Pharmaceutical Co Ltd Proposes Amendments to the Articles of Association

Zhejiang Huahai Pharmaceutical co Ltd. announced that at the AGM to be held on April 27, 2015, the shareholders will consider amendments to the company's articles of association.

Zhejiang Huahai Pharmaceutical co Ltd, Annual General Meeting, Apr 27, 2015

Zhejiang Huahai Pharmaceutical co Ltd, Annual General Meeting, Apr 27, 2015., at 14:30 China Standard Time. Agenda: To consider 2014 work report of the board of directors; to consider 2014 work report of the supervisory committee; to consider 2014 financial resolution report; to consider 2014 profit distribution plan; to consider 2014 annual report and its summary; to consider amendments to the Company's articles of association; to consider amendments to the Company's rules of procedures governing shareholders' general meetings; and to consider reappointment of audit firm.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600521:CH CNY25.52 CNY 0.00

600521 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600521.
View Industry Companies
 

Industry Analysis

600521

Industry Average

Valuation 600521 Industry Range
Price/Earnings 64.5x
Price/Sales 7.1x
Price/Book 5.9x
Price/Cash Flow 64.0x
TEV/Sales 6.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HUAHAI PHARMACEUT-A, please visit www.huahaipharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.